Table 1 Patient clinical features and SLC34A2 expression profile
Patient No. | Age | Gender | Histological grade | Clinical stage | Normalised SLC34A2 amount in tumour tissue relative to adjacent normal tissue 2-ΔΔCt | Lymph node metastatic or non-metastatic |
|---|---|---|---|---|---|---|
1 | 54 | F | A | IIIA | 0.5675 | Yes |
2 | 53 | F | A | IA | 0.0715 | No |
3 | 74 | F | A | IIA | 0.0585 | Yes |
4 | 71 | M | A | IB | 0.1675 | No |
5 | 52 | F | A | IB | 0.2573 | No |
6 | 59 | F | A | IIIB | 0.2829 | Yes |
7 | 79 | F | A | IB | 0.4157 | No |
8 | 74 | F | A | IB | 0.3364 | No |
9 | 61 | F | A | IIIA | 0.1702 | Yes |
10 | 69 | F | A | IIB | 0.4994 | No |
11 | 64 | F | A | IIA | 3.3600 | No |
12 | 67 | M | A | IIA | 0.6622 | No |
13 | 81 | M | S | IV | 0.2813 | Yes |
14 | 50 | M | S | IIA | 0.1462 | No |
15 | 55 | M | S | IIIA | 0.5016 | Yes |